Skip to content

Clinical trials

Phase 4 Tachycardia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tachycardia Phase: Phase 4 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20061
20081
20131
20142
20171
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation2
Fahim Khorfan, MD1
LivaNova1
Loyola University1
Merck Sharp & Dohme LLC1
State University of New York at Buffalo1
University of Chicago1
Vanderbilt University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tachycardia9
Arrhythmias, Cardiac3
Shock3
Bradycardia2
Sepsis2
Atrial Fibrillation1
Diabetes Insipidus1
Heart Failure1
Pulmonary Disease, Chronic Obstructive1
Shock, Cardiogenic1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.